Home › Funds › Madison Avenue Partners, LP › SOLV
Madison Avenue Partners, LP position in SOLV
SOLVENTUM CORP · Health Care
Madison Avenue Partners, LP reported holding 1,741,221 shares of SOLV (SOLVENTUM CORP) in its Q2 2026 13F filing — a position valued at US$134.3M, representing 5.78% of its reported portfolio and ranking #7 among its reported holdings. Madison Avenue Partners, LP has disclosed SOLV holdings in 9 of the last 9 reported quarters, going back to Q2 2024.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Madison Avenue Partners, LP's SOLV position evolved
Madison Avenue Partners, LP first disclosed a stake in SOLV in Q2 2024 at 2,464,934 shares (US$130.3M). The position peaked in Q1 2025 at 2,813,017 shares, worth US$213.9M. Across 9 filings, Madison Avenue Partners, LP increased the stake 1 time(s), trimmed it 5 time(s) and left it unchanged 2 time(s). The most recent filing (Q2 2026) shows 1,741,221 shares valued at US$134.3M — a reduction of -134,515 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2024 | 2.46M | $130.35M | New |
| Q3 2024 | 2.83M | $197.15M | Add |
| Q4 2024 | 2.83M | $186.80M | Hold |
| Q1 2025 | 2.81M | $213.90M | Reduce |
| Q2 2025 | 2.24M | $170.21M | Reduce |
| Q3 2025 | 1.99M | $145.15M | Reduce |
| Q4 2025 | 1.99M | $157.53M | Hold |
| Q1 2026 | 1.88M | $122.49M | Reduce |
| Q2 2026 | 1.74M | $134.34M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About SOLV and 13F data
SOLV (SOLVENTUM CORP) is a Health Care company. 44 other funds we track also report a position in SOLV — the largest reported positions include Independent Franchise Partners LLP (US$1.25B), TRIAN FUND MANAGEMENT, L.P. (US$635.5M), DAVIS SELECTED ADVISERS (US$486.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding SOLV
- Independent Franchise Partners LLP 16.17M sh · $1.25B · Q2 2026
- TRIAN FUND MANAGEMENT, L.P. 8.24M sh · $635.47M · Q2 2026
- DAVIS SELECTED ADVISERS 6.31M sh · $486.69M · Q2 2026
- Diamond Hill Capital Management, LLC (Investment Advisor) 1.95M sh · $150.07M · Q2 2026
- EQUITY INVESTMENT CORP 882.02K sh · $68.05M · Q2 2026
- Ruffer LLP 776.47K sh · $59.84M · Q2 2026
- ANCHOR CAPITAL ADVISORS LLC 582.76K sh · $44.96M · Q2 2026
More on Madison Avenue Partners, LP
FAQ
How long has Madison Avenue Partners, LP held SOLV?
Madison Avenue Partners, LP has disclosed SOLV holdings in 9 of the last 9 reported quarters, going back to Q2 2024.
What is Madison Avenue Partners, LP's current position in SOLV?
As of Q2 2026, Madison Avenue Partners, LP holds 1.74M shares of SOLV (SOLVENTUM CORP), valued at $134.34M, representing 5.78% of its reported portfolio and ranking #7.
Has Madison Avenue Partners, LP been buying or selling SOLV?
In the latest 13F filing (Q2 2026), Madison Avenue Partners, LP reduced its position in SOLV. The position peaked in Q1 2025 at 2.81M shares.
Which other funds hold SOLV?
Other major institutional holders of SOLV include Independent Franchise Partners LLP, TRIAN FUND MANAGEMENT, L.P., DAVIS SELECTED ADVISERS, among 44 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.